Autolus Therapeutics PLC (AUTL, Financial) is set to release its Q1 2025 earnings on May 8, 2025. The consensus estimate for Q1 2025 revenue is $2.06 million, and the earnings are expected to come in at -$0.26 per share. The full year 2025's revenue is expected to be $36.87 million, and the earnings are expected to be -$0.92 per share. More detailed estimate data can be found on the Forecast page.
Autolus Therapeutics PLC (AUTL, Financial) Estimates Trends
Revenue estimates for Autolus Therapeutics PLC (AUTL) have declined from $50.80 million to $36.87 million for the full year 2025, and from $126.42 million to $117 million for 2026 over the past 90 days. Earnings estimates have declined from -$0.84 per share to -$0.92 per share for the full year 2025, and from -$0.65 per share to -$0.73 per share for 2026 over the past 90 days.
Autolus Therapeutics PLC (AUTL, Financial) Reported History
In the previous quarter of December 31, 2024, Autolus Therapeutics PLC's (AUTL) actual revenue was $0.03 million, which missed analysts' revenue expectations of $2.98 million by 99.03%. Autolus Therapeutics PLC's (AUTL) actual earnings were -$0.10 per share, which beat analysts' earnings expectations of -$0.20 per share by 50.50%. After releasing the results, Autolus Therapeutics PLC (AUTL) was down by 13.66% in one day.
Autolus Therapeutics PLC (AUTL, Financial) 12 Month Price Targets
Based on the one-year price targets offered by 10 analysts, the average target price for Autolus Therapeutics PLC (AUTL) is $9.81, with a high estimate of $14 and a low estimate of $6. The average target implies an upside of 745.69% from the current price of $1.16.
Based on GuruFocus estimates, the estimated GF Value for Autolus Therapeutics PLC (AUTL, Financial) in one year is $4.88, suggesting an upside of 320.69% from the current price of $1.16.
Based on the consensus recommendation from 11 brokerage firms, Autolus Therapeutics PLC's (AUTL, Financial) average brokerage recommendation is currently 1.6, indicating an "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
